| Q36810081 | A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial |
| Q46878059 | A one-step method of 10,17-dihydro(pero)xydocosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid synthesis by soybean lipoxygenase |
| Q37060108 | A review of complementary and alternative approaches to immunomodulation |
| Q35550952 | A simple method of supplementation of omega-3 polyunsaturated fatty acids: use of fortified yogurt in healthy volunteers. |
| Q35932966 | Activation and resolution of periodontal inflammation and its systemic impact |
| Q36409418 | Advances in immunology: from bench to bedside--a symposium at the 2005 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, MA, USA. |
| Q38370798 | An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. |
| Q47979606 | Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. |
| Q34022356 | Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity. |
| Q37710276 | Anti-inflammatory diets for obesity and diabetes |
| Q34189477 | Anti-inflammatory nutrition as a pharmacological approach to treat obesity |
| Q90049947 | Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation |
| Q36329171 | Arachidonic acid metabolites in pathogenic yeasts. |
| Q37612179 | Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial |
| Q37649591 | Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review |
| Q28084681 | Beneficial effects of omega-3 polyunsaturated Fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesity |
| Q34010058 | Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA). |
| Q40105742 | Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB. |
| Q38699127 | Combining Human and Rodent Genetics to Identify New Analgesics |
| Q33507109 | Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis |
| Q36831450 | Control of oxygenation in lipoxygenase and cyclooxygenase catalysis |
| Q55206336 | Diclofenac - induced hepatotoxicity: Low dose of omega-3 fatty acids have more protective effects. |
| Q33702786 | Diet-gene interactions and PUFA metabolism: a potential contributor to health disparities and human diseases |
| Q36827940 | Dietary Cholesterol Increases the Risk whereas PUFAs Reduce the Risk of Active Tuberculosis in Singapore Chinese |
| Q38169805 | Dietary modulation of the inflammatory cascade |
| Q36804834 | Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. |
| Q57375098 | Dihydroxydocosahexaenoic acids of the neuroprotectin D family: synthesis, structure, and inhibition of human 5-lipoxygenase |
| Q33694562 | Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. |
| Q35233123 | Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro |
| Q42725708 | Effect of ω-3 fatty acid on gastrointestinal motility after abdominal operation in rats |
| Q33963239 | Effects of ω3- and ω6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. |
| Q36277134 | Enzymatic synthesis of a bicyclobutane fatty acid by a hemoprotein lipoxygenase fusion protein from the cyanobacterium Anabaena PCC 7120. |
| Q56699406 | Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells |
| Q58115392 | Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD Pathology |
| Q47918598 | Expression of DHA-Metabolizing Enzyme Alox15 is Regulated by Selective Histone Acetylation in Neuroblastoma Cells |
| Q36965010 | Fatty acids and immune function: new insights into mechanisms |
| Q33670777 | Fish intake during pregnancy and the risk of child asthma and allergic rhinitis - longitudinal evidence from the Danish National Birth Cohort. |
| Q36353394 | Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues |
| Q28085111 | Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease |
| Q38809442 | Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes |
| Q37072003 | Gender differences in the n-3 fatty acid content of tissues |
| Q33805039 | Genetic Variants in the FADS Gene: Implications for Dietary Recommendations for Fatty Acid Intake |
| Q35606701 | Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes |
| Q37848939 | Impact of fatty acid status on immune function of children in low-income countries |
| Q36916748 | Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents |
| Q35817458 | Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis |
| Q38340154 | Industrial potential of lipoxygenases. |
| Q37544889 | Inflammatory disease processes and interactions with nutrition |
| Q36395903 | Inhibition of lipogenesis reduces inflammation and organ injury in sepsis |
| Q37345889 | Integrative medicine in gastrointestinal disease: evaluating the evidence |
| Q58895391 | Interactions Between Omega-3 Fatty Acids and Iron |
| Q37770134 | Interactions between immunity and metabolism - contributions from the metabolic profiling of parasite-rodent models |
| Q37328073 | Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids |
| Q34114895 | Is there a role for fatty acids in early life programming of the immune system? |
| Q35332267 | Isoprostane generation and function |
| Q39863996 | Mechanisms underlying the immunomodulatory effects of n-3 PUFA. |
| Q36947010 | Multi-targeted therapy of cancer by omega-3 fatty acids |
| Q90704424 | N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications |
| Q46898220 | N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. |
| Q33910127 | Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid |
| Q37793723 | Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species |
| Q46547883 | Novel oxylipins formed from docosahexaenoic acid by potato lipoxygenase--10(S)-hydroxydocosahexaenoic acid and 10,20-dihydroxydocosahexaenoic acid |
| Q35930091 | Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease |
| Q36800748 | Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods |
| Q33796324 | Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage |
| Q33897279 | Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis |
| Q26851574 | Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition |
| Q41149645 | Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner |
| Q26773056 | Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy |
| Q33677382 | Omega-3 fatty acids and cognitive function in women |
| Q24681087 | Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? |
| Q38152943 | Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management |
| Q27686781 | Omega-3s and cardiovascular health. |
| Q46693482 | On the structure and synthesis of neuroprotectin D1, a novel anti-inflammatory compound of the docosahexaenoic acid family |
| Q38180557 | Oxidized fatty acids as inter-kingdom signaling molecules |
| Q37566230 | Oxylipin diversity in the diatom family Leptocylindraceae reveals DHA derivatives in marine diatoms. |
| Q37833673 | Oxylipins in fungi. |
| Q34172107 | Perinatal nutrition and immunity to infection |
| Q37385799 | Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis |
| Q41661897 | Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q37078153 | Progress in nutritional immunology |
| Q38804214 | Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture |
| Q24564308 | Regulation of inflammation in cancer by eicosanoids |
| Q33882297 | Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss |
| Q36309261 | Resolution of inflammation in periodontitis |
| Q43039392 | Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression |
| Q34448487 | Resolvins: natural agonists for resolution of pulmonary inflammation. |
| Q34334822 | Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies |
| Q38116485 | Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. |
| Q28244502 | Roles of resolvins in the resolution of acute inflammation |
| Q37291411 | Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis |
| Q54980113 | Signaling pathways activated by resolvin E1 to stimulate mucin secretion and increase intracellular Ca2+ in cultured rat conjunctival goblet cells. |
| Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
| Q28268731 | Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production |
| Q64947282 | The Effect of Omega-3 and Omega-6 Polyunsaturated Fatty Acids on the Production of Cyclooxygenase and Lipoxygenase Metabolites by Human Umbilical Vein Endothelial Cells. |
| Q42910135 | The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats |
| Q38114076 | The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer. |
| Q35108122 | The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition |
| Q34578129 | The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer |
| Q37024748 | The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study |
| Q89928637 | Therapeutic potential of omega-3 fatty acids supplementation in a mouse model of dry macular degeneration |
| Q34163864 | Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemia |
| Q90341440 | Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis |
| Q37797642 | Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease? |
| Q36595126 | Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS |
Search more.